Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-03-000416
Filing Date
2003-03-04
Accepted
2003-03-04 12:56:51
Documents
1
Period of Report
2003-03-01

Document Format Files

Seq Description Document Type Size
1 bucalo_f4-030103.txt 4 12246
  Complete submission text file 0001019687-03-000416.txt   14101
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 03590865
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
BUCALO LOUIS R MD (Reporting) CIK: 0001180760 (see all company filings)